Adaptimmune’s Adrian Rawcliffe On Changing Our Relationship With Cancer

Adaptimmune’s Tecelra recently became the first TCR cell therapy approved in the US, and CEO Adrian Rawcliffe explains why cell therapies could transform all cancer treatments.
An excerpt from "T-Cells For The Win With Adaptimmune's Adrian Rawcliffe" - check out the full video at www.bioprocess...
---
#businessofbiotech #biopharma #biotech
Subscribe to the podcast:
Apple - podcasts.apple...
Spotify - open.spotify.c...
TH-cam - • The Business Of Biotec...